JP2022523552A5 - - Google Patents

Info

Publication number
JP2022523552A5
JP2022523552A5 JP2021552598A JP2021552598A JP2022523552A5 JP 2022523552 A5 JP2022523552 A5 JP 2022523552A5 JP 2021552598 A JP2021552598 A JP 2021552598A JP 2021552598 A JP2021552598 A JP 2021552598A JP 2022523552 A5 JP2022523552 A5 JP 2022523552A5
Authority
JP
Japan
Application number
JP2021552598A
Other languages
Japanese (ja)
Other versions
JP7748874B2 (ja
JP2022523552A (ja
JPWO2020178738A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/051807 external-priority patent/WO2020178738A1/en
Publication of JP2022523552A publication Critical patent/JP2022523552A/ja
Publication of JPWO2020178738A5 publication Critical patent/JPWO2020178738A5/ja
Publication of JP2022523552A5 publication Critical patent/JP2022523552A5/ja
Application granted granted Critical
Publication of JP7748874B2 publication Critical patent/JP7748874B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021552598A 2019-03-04 2020-03-03 T細胞受容体及びその使用方法 Active JP7748874B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962813639P 2019-03-04 2019-03-04
US62/813,639 2019-03-04
PCT/IB2020/051807 WO2020178738A1 (en) 2019-03-04 2020-03-03 T cell receptors and methods of use thereof

Publications (4)

Publication Number Publication Date
JP2022523552A JP2022523552A (ja) 2022-04-25
JPWO2020178738A5 JPWO2020178738A5 (https=) 2023-03-13
JP2022523552A5 true JP2022523552A5 (https=) 2023-03-13
JP7748874B2 JP7748874B2 (ja) 2025-10-03

Family

ID=72336933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021552598A Active JP7748874B2 (ja) 2019-03-04 2020-03-03 T細胞受容体及びその使用方法

Country Status (13)

Country Link
US (1) US20220169695A1 (https=)
EP (1) EP3935173A4 (https=)
JP (1) JP7748874B2 (https=)
KR (1) KR20210149051A (https=)
CN (1) CN113853434B (https=)
AU (1) AU2020231106A1 (https=)
BR (1) BR112021017486A2 (https=)
CA (1) CA3132252A1 (https=)
IL (1) IL286032A (https=)
MX (1) MX2021010533A (https=)
SG (1) SG11202109588RA (https=)
TW (1) TWI875737B (https=)
WO (1) WO2020178738A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7748284B2 (ja) 2019-03-04 2025-10-02 ユニバーシティー ヘルス ネットワーク T細胞受容体及びその使用方法
MX2021010541A (es) 2019-03-04 2021-12-15 Univ Health Network Receptores de linfocitos t y metodos de uso de estos.
CN113795586B (zh) 2019-03-25 2026-03-27 大学健康网络 T细胞受体及其使用方法
WO2022099543A1 (zh) * 2020-11-12 2022-05-19 深圳先进技术研究院 Ny-eso-1基因抑制剂作为抗肿瘤化疗药物增敏剂的应用
CN117843800A (zh) * 2023-12-01 2024-04-09 浙江大学 一种靶向胞内ny-eso-1的双特异抗体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506875B1 (en) * 2000-09-26 2003-01-14 Ludwig Institute For Cancer Research Isolated peptides which bind to HLA-C molecules and uses thereof
WO2008042407A1 (en) * 2006-10-03 2008-04-10 Ludwig Institute For Cancer Research Melanoma repopulating cells
US8105831B2 (en) * 2007-03-09 2012-01-31 University Of Washington Parvoviral production of HLA homozygous cells
US9051391B2 (en) * 2007-06-11 2015-06-09 Takara Bio Inc. Method for expression of specific gene
ES2635335T3 (es) 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
WO2014160030A2 (en) * 2013-03-13 2014-10-02 Health Research, Inc. Compositions and methods for use of recombinant t cell receptors for direct recognition of tumor antigen
AU2015343013B2 (en) * 2014-11-05 2020-07-16 Board Of Regents, The University Of Texas System Gene modified immune effector cells and engineered cells for expansion of immune effector cells
WO2017120428A2 (en) * 2016-01-06 2017-07-13 Health Research, Inc. Compositions and libraries comprising recombinant t-cell receptors and methods of using recombinant t-cell receptors
AU2017226199A1 (en) * 2016-03-04 2018-09-13 New York University Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity

Similar Documents

Publication Publication Date Title
CN306240235S (https=)
CN306245198S (https=)
CN306154096S (https=)
CN306155201S (https=)
CN306155359S (https=)
CN306163544S (https=)
CN306164856S (https=)
CN306165456S (https=)
CN306166296S (https=)
CN306166641S (https=)
CN306167178S (https=)
CN306167995S (https=)
CN306169143S (https=)
CN306169755S (https=)
CN306169966S (https=)
CN306171260S (https=)
CN306172129S (https=)
CN306174565S (https=)
CN306069923S (https=)
CN306192341S (https=)
CN306192594S (https=)
CN306193217S (https=)
CN306193241S (https=)
CN306193603S (https=)
CN306202766S (https=)